Visibility
What produced the price? Which assumptions entered the analysis? Who shaped the narrative before leadership entered?
Leadership controls the capital. CrestWatch focuses on the process, economics, and decision rights behind the recommendation.
Claims accumulate. Contracts operate. Pharmacy costs move. Reserves change. Vendors perform. Decisions are made — or deferred.
The renewal is not the strategy. It is the visible output of the system that operated all year.
Can employees absorb the change without disruption?
What must the organization absorb financially?
Is there sufficient reason to disturb a trusted relationship?
Three omissions repeatedly weaken the employer's field of view.
What produced the price? Which assumptions entered the analysis? Who shaped the narrative before leadership entered?
Who owns the data, reserves, surplus, rebates, contracts, and favorable economic value your organization funds?
Which operating models qualified? Which institutions never entered the room? What could have changed before renewal?
Employers are rarely taught that materially different outcomes can require materially different people in the room. Independent underwriting, administration, pharmacy, funding, and claims operators are not interchangeable with the carrier and retail brokerage process.
The carrier underwrites risk for the carrier's decision. Who independently established what your organization's risk supports for your decision?
Did leadership ever directly meet the people responsible for administration, claims, pharmacy, underwriting, and risk — and question how their model works?
Who controls reserves, surplus, rebates, data, contracts, favorable value, and termination rights?
Which private TPA, pass-through PBM, consortium, captive, or employer-owned structures were actually eligibility-tested, underwritten, and modeled?
Which alternatives disappeared before the recommendation reached leadership — and who controlled that access?
What authority does leadership possess to intervene, replace, renegotiate, or redirect before the next renewal?
What shaped the recommendation. What never entered the process. Who was never brought to the table. What your organization may actually qualify to examine.
See The Decision ArchitectureThe product changes. The choreography governing underwriting, access, economics, and choice often does not.
Employer risk → carrier underwriting → brokerage market frame → internal validation → options presented → renewal narrative → recommendation → leadership approval.
Independent examination begins before commitment — not after it.
Independent employer-side underwriting separates the employer's actual claims and risk profile from the carrier's product architecture, trend assumptions, pooling rules, and pricing objectives.
What produced the price? Which assumptions entered the analysis? What was removed before presentation?
Who owns the data, reserves, surplus, rebates, contracts, and unused economic value your organization funds?
Which alternatives did your organization qualify to examine? Who could leadership have questioned directly?
An improved offer is not the problem. Its timing changes the evidence. The account-saving meeting is evidence of capability that was not previously inside leadership's field of view.
Employee disruption. Enrollment. Payroll integration. Provider access. Communications. Executive complaints.
Those are not reasons to avoid independent examination. They are reasons the examination must happen early enough to protect continuity.
The retention meeting reveals what the incumbent can do. CrestWatch examines why your organization had to signal departure before those capabilities entered the room.
The economics producing it often are not.
Price does not reveal who retains favorable value, what rights survive, or what authority exists between renewals.
Claims. Administration. Pharmacy. Stop-loss. Reserves. Compensation.
Unexamined margin, pharmacy leakage, retained reserves, duplicated administration, unsuitable funding, and assumptions accepted year after year can become recurring economics. Savings are an outcome of better decisions — not the doctrine.
Direct, indirect, contingent, retention, and placement compensation do not automatically invalidate a recommendation. Leadership should be able to see the incentive and evaluate the recommendation with it in view.
Fully insured, carrier level funding, and private-TPA structures transfer and retain different rights, economics, and authority.
The carrier establishes the price for the risk it agrees to assume. The employer sees the premium, but not necessarily the complete economics behind the decision.
Surplus treatment, claims corridors, stop-loss, data rights, reserve ownership, termination provisions, and mid-year authority remain contract questions.
The employer can select operating partners and define contractual accountability around claims, data, pharmacy, networks, reporting, and intervention.
Then establish the strategy. Then deploy the capabilities the strategy requires.
CrestWatch independently establishes risk, traces economics, tests the qualified market, strengthens employer decision rights, and coordinates the capabilities required to execute throughout the year.
Federal transparency and disclosure requirements have increased what plan fiduciaries can see about service-provider compensation. But disclosure is not the same as governance. Prudence still depends on how the employer evaluates, selects, monitors, and documents the service providers and arrangements supporting the plan.
CAA-era disclosure rules require certain brokers and consultants serving ERISA group health plans to disclose direct and indirect compensation to the responsible plan fiduciary.
ERISA prudence focuses on process: understanding fees, comparing service providers, reviewing contracts, and documenting why the selected arrangement is reasonable.
The Department of Labor advises employers to establish a formal review process and periodically monitor service-provider performance, actual fees, practices, and plan records.
The law evolved. The market evolved. The economics evolved. An annual renewal process built primarily for price negotiation does not automatically become a fiduciary governance process.
What does your organization's actual risk support?
Where do the dollars go, who retains value, and what rights belong to your organization?
Which operating models and institutions did your organization qualify to examine?
Who shaped the assumptions, field of choice, narrative, and recommendation before leadership?
What can leadership see, challenge, change, and control throughout the year?
Claims visibility, large-claim alerts, operating performance, and emerging risk.
Strategic review against documented goals, vendor performance, pharmacy, and economics.
Decision point: what should change before renewal pressure compresses the field?
Leadership receives the output of a strategy already examined, not the first moment strategy becomes visible.
Independent underwriting. TPA and PBM evaluation. Claims intervention. Alternative funding. Compliance. Enterprise risk. Executive governance cadence.
Carrier, TPA, PBM, payroll, eligibility, enrollment, communications, COBRA, and implementation milestones are coordinated so strategy becomes operational reality.
Claims escalation, employee education, compliance, vendor accountability, strategic reviews, and mid-year decisions continue after renewal.
Actuarial, TPA, PBM, claims, compliance, and risk specialists enter when the employer's strategy requires them — not simply because they are bundled into a product.
CrestWatch coordinates the operating work required to move from examination to implementation without asking HR or leadership to carry the transition alone.
Large-claim visibility, escalation protocols, nurse case management, provider navigation, and documented intervention paths.
Independent TPA evaluation, pass-through pharmacy review, formulary and contract analysis, rebate economics, and vendor accountability.
Carrier, TPA, PBM, payroll, eligibility, enrollment, communications, COBRA, and new-hire coordination through implementation.
ERISA and Form 5500 review, wrap documentation, disclosure review, filing remediation, and documented governance checkpoints.
Claims visibility, quarterly strategic reviews, funding and vendor evaluation, renewal variance tracking, and defined decision points before renewal pressure.
Benefits, workers' compensation, property, cyber, liability, executive risk, business continuity, succession, and specialist coordination under one employer-side framework.
Leadership experience spans global brokerage, national carrier environments, benefits, risk management, human resources, enterprise risk, and advanced professional education.
Independent evaluation requires independent incentives. CrestWatch's role, compensation, and implementation relationships are disclosed so your leadership team can examine our interests alongside everyone else's.
A private employer-side examination of the risk, economics, market access, operating alternatives, and decision rights behind your current strategy.
Request A Private Employer Control Examination